inclusion criteria: willing to participate in the study and provide written informed consent male and female adults aged > 18 years and less than 65 years must have had clinically suspected covid-19 and a positive antibody test or a documented sars-cov-2 infection (a positive reverse transcription polymerase chain reaction test) at least 12 weeks prior to screening must have fatigue-predominant pasc other than pasc, a subject must be in good health without other significant medical or not well controlled medical or psychiatric conditions

inclusion criteria: willing to participate in the study and provide written informed consent male and female adults aged > 18 years and less than 65 years must have had clinically suspected covid-19 and a positive antibody test or a documented sars-cov-2 infection (a positive reverse transcription polymerase chain reaction test) at least 12 weeks prior to screening must have fatigue-predominant pasc other than pasc, a subject must be in good health without other significant medical or not well controlled medical or psychiatric conditions